Compound name
SGC-CDKL5_GSK3
Protein family
Protein Kinase
Target name
CDKL5
Affinity biochemical (nM)
6.5
Affinity on-target cellular (nM)
3.5
CG-Set
Kinase set
Recommended Concentration
100 nM
Compound EUbOPEN ID
EUB0002314a
SMILES
O=C(Nc1c[nH]nc1C(=O)NC1CCNCC1)c1cc(F)cc(F)c1
InChIKey
NIHAFOURWLZLFN-UHFFFAOYSA-N
NCBI gene ID
6792
UniProt ID
O76039
Synonyms
EIEE2, CFAP247
Mode of action
inhibitor
Negative control
SGC-CDKL5/GSK3-1N
Affinity biochemical definition
IC50
Affinity biochemical assay type
KinaseSeeker homogenous competition binding assay (Luceome Biotechnologies)
Affinity Biochemical Source Knowledge
https://pubmed.ncbi.nlm.nih.gov/37084253/
Affinity biochemical relation
0
Affinity on-target cellular definition
IC50
Affinity on-target cellular assay type
NanoBRET assay (HEK293T cells)
Affinity on-target cellular source knowledge
https://pubmed.ncbi.nlm.nih.gov/37084253/
Affinity on-target cellular relation
0
Selectivity platform
DiscoverX (scanMAX)
Selectivity platform number of targets
403
Selectivity remarks
Screened at 1 µM, closest targets as % of control: CDKL5 (0.2%), GSK3B (0.5%), DYRK2 (4.8%), CDK7 (5.6%), CDK16 (12%), GSK3A (14%), DYRK1A (19%), CDK17 (20%), HIPK1 (33%), HIPK2 (33%), RPS6KA4 (34%); In-vitro potency (enzymatic radiometric assays, Eurofins): IC50(DYRK2) = 770 nM, IC50(CDK7) >10000 nM, IC50(CDK16) = 590 nM, IC50(DYRK1A) = 1100 nM, IC50(CDK17) = 1000 nM, IC50(HIPK1) = 7900 nM, IC50(HIPK2) = 2300 nM, IC50(RPS6KA4) >10000 nM
Selectivity Source Knowledge
https://pubmed.ncbi.nlm.nih.gov/37084253/
Selectivity Number of Off-targets
2